Meningovascular syphilis as a cause of basilar artery stenosis
Neurol 64:391-392, Flint, A.C., et al, 2005
The Role of Levodopa in the Management of Dementia With Lewy Bodies
JNNP 76:1200-1203, Moloy,S.,et al, 2005
Cholinesterase Inhibitors for Patients with Alzheimers Disease: Systematic Review of Randomised Clinical Trials
BMJ 331:321-323, Kaduszkiewicz,H.,et al, 2005
Carbamazepine Encephalopathy Masquerading as Creutzfeldt-Jakob Disease
Neurol 65:650-651, Horvath,J.,et al, 2005
Clinicopath Conf, Prion Disease (Sporadic Creutzfeldt-Jakob Disease)
NEJM 353:1042-1050, Case 27-2005, 2005
Neuropathology of Dementia in Parkinsons Disease: A Prospective, Community-Based Study
Ann Neurol 58:773-776,663, Aarsland,D.,et al, 2005
Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia, Meta-analysis of Randomized Placebo-Controlled Trials
JAMA 294:1934-1943,1963, Schneider,L.S.,et al, 2005
Delayed Neurotoxicity in Primary Central Nervous System Lymphoma
Arch Neurol 62:1595-1600, Omuro,A.M.P.,et al, 2005
Early Posttraumatic Subarachnoid Hemorrhage Due to Dissecting Aneurysms in Three Children
Neurol 65:1663-1665, Kneyber,M.C.J.,et al, 2005
Lipid Lowering Agents Are Associated With a Slower Cognitive Decline in Alzheimers Disease
JNNP 76:1624-1629, Masse,I.,et al, 2005
Clinicopath Conf., MELAS Syndrome
NEJM 353:2271-2280, Case 36-2005, 2005
Global Prevalence of Dementia: A Delphi Consensus Study
Lancet 366:2112-2117, Ferri,C.P.,et al, 2005
Diagnosis and Management of Dementia with Lewy Bodies
Neurol 65:1863-1872, McKeith,I.G.,et al, 2005
Genetic Factors in Alzheimer's Disease
NEJM 352: 862-863, 884, Bird, T., 2005
Unawareness of Cognitive Deficit (Cognitive Anosognosia) in Probable AD and Control Subjects
Neurol 64:693-699, Barrett, A.M., et al, 2005
Steroid Dementia: an Overlooked Diagnosis?
Neurol 64:707-709, Sacks,O. & Shulman,M., 2005
Specialist Palliative Care in Dementia
BMJ 330:57-58, Chen,F. & Majeed,A., 2005
Recent Developments in Pain in Dementia
BMJ 330:461-464, Scherder,E., et al, 2005
Atypical Antipsychotic Drugs and Risk of Ischaemic Stroke: Population Based Retrospective Cohort Study
BMJ 330:445-448, Gill,S.S., et al, 2005
Neurocardiogenic Syncope
NEJM 352:1004-1010, Grubb, B.P., 2005
Pharmacological treatment of Neuropsychiatric Symptoms of Dementia
JAMA 293:596-608, Sink,K.M.,et al, 2005
The Genetic Causes of Basal Ganglia Calcification, Dementia, and Bone Cysts
Neurol 64:1502-1507, Klunemann,H.H.,et al, 2005
Metabolic Patterns Associated with the Clinical Response to Galantamine Therapy
Arch Neurol 62:721-728, Mega,M.S.,et al, 2005
Atorvastatin for the Treatment of Mild to Moderate Alzheimer Disease
Arch Neurol 62:753-757, Sparks,D.L.,et al, 2005
Deaths with Antipsychotics in Elderly Patients with Behavioral Disturbances
Dept Health & Human Services (Apr), FDA Public Health Advisory, 2005
Donepezil for Dementia in Parkinsons Disease: A Randomised, Double Blind, Placebo Controlled, Crossover Study
JNNP 76:934-939,903, Ravina,B.,et al, 2005
The "Pulvinar Sign" in a Case of Paraneoplastic Limbic Encephalitis Associated with Non-Hodgkins Lymphoma
JNNP 76:882-884, Mihara,M.,et al, 2005
Vitamin E and Donepezil for the Treatment of Mild Cognitive Impairment
NEJM 352:2379-2388,2439, Petersen,R.C.,et al, 2005
Frontotemporal Lobar Degeneration
Arch Neurol 62:925-930, Johnson,J.K.,et al, 2005
Diffusion-Weighted and Fluid-Attenuated Inversion Recovery Imaging in Creutzfeldt-Jakob Disease:High Sensitivity and Specificity for Diagnosis
AJNR 26:1551-1562, Young,G.S.,et al, 2005
A 10-Item Smell Identification Scale Related to Risk for Alzheimers Disease
Ann Neurol 58:155-160, Taberr,M.H.,et al, 2005
Statin Use and the Risk of Incident Dementia
Arch Neurol 62:1047-1051, Rea,T.D.,et al, 2005
Different Patterns of Magnetic Resonance Imaging Atrophy for Frontotemporal Lobar Degeneration Syndromes
Arch Neurol 62:1106-1110, Short,R.A.,et al, 2005
Delusions and Hallucinations in Dementia with Lewy Bodies: Worsening with Memantine
Neurol 65:481-482, Ridha,B.H.,et al, 2005
Creutzfeldt-Jakob Disease Mimicking Radiologic Posterior Reversible Leukoencephalopathy
Neurol 65:329, Sibon,I.,et al, 2005
Psychiatric Manifestations of Creutzfeldt-Jakob Disease: A 25-Year Analysis
J Neuropsychiatry Clin Neurosci 17:489-495, Wall,C.A.,et al, 2005
Angiography-Negative Primary Central Nervous System Vasculitis in Children
Arthritis Rheum 52:2159-2167, Benseler, S.M.,et al, 2005
Serial Diffusion-Weighted MRI of Creutzfeldt-Jakob Disease
AJR 184:560-566, Ukisu,R.,et al, 2005
Injuries Due to Seizures in Persons with Epilepsy
Neurol 63:1565-1570, Lawn,N.D.,et al, 2004
The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline
JAMA 292:2237-2242, Yaffe,K.,et al, 2004
Diabetes Mellitus in Midlife and the Risk of Dementia Three Decades Later
Neurol 63:1902-1907, Beeri,M.S.,et al, 2004
Memory Complaints in Nondemented Men Predict Future Pathologic Diagnosis of Alzheimer Disease
Neurol 63:1960-1961, Jorm,A.F.,et al, 2004
CJD--A Case of Mistaken Identity
Lancet 364:2068, Campbell,S.,et al, 2004
Rivastigmine for Dementia Associated with Parkinson's Disease
NEJM 351:2509-2518,2547, Emre,M.,et al, 2004
Neurosyphillis in the Modern Era
JNNP 75:1727-1730, Timmermans,M. &Carr,J., 2004
Mixed Dementia, Emerging Concepts and Therapeutic Implications
JAMA 292:2901-2908, Langa,K.M.,et al, 2004
Reduced Risk of Alzheimer Disease in Users of Antioxidant Vitamin Supplements
Arch Neurol 61:82-88, Zandi,P.P.,et al, 2004
Tissue Distribution of Bovine Spongiform Encephalopathy Agent in Primates after Intravenous or Oral Infection
Lancet 363:422-428,411, Herzog,C.,et al, 2004
Possible Transmission of Variant Creutzfeldt-Jakob Disease by Blood Transfusion
Lancet 363:417-421,411, Llewelyn,C.A.,et al, 2004
Treatment-Induced Leukoencephalopathy in Primary CNS Lymphoma,A Clinical and Autopsy Study
Neurol 62:451-456, Lai,R.,et al, 2004